Neo Kumfurt Pawxy is a broad-spectrum veterinary antibiotic belonging to the oral cephalosporin class, formulated to provide effective treatment against a wide range of bacterial infections in dogs. With its excellent pharmacokinetic profile and prolonged half-life, Pawxy offers the convenience of once-daily dosing, helping improve treatment compliance and clinical outcomes.
Pawxy is effective against several important bacterial pathogens commonly associated with skin, soft tissue, and respiratory tract infections in dogs. Its time-dependent antibacterial activity allows sustained therapeutic concentrations, helping eliminate susceptible bacteria while reducing the burden of infection.
The formulation is particularly useful in the management of skin infections, wounds, abscesses, respiratory tract infections, and as part of antibacterial coverage during surgical interventions. The convenient once-daily dosing schedule makes administration easier for pet owners and helps ensure better adherence to veterinary treatment protocols.
Pawxy is trusted by veterinarians for its broad antibacterial coverage, excellent tissue penetration, and proven efficacy against susceptible Gram-positive and Gram-negative organisms. It should be administered strictly under veterinary supervision and according to the prescribed dosage schedule.
KEY BENEFITS
- Broad-spectrum antibacterial activity
- Oral cephalosporin antibiotic formulation
- Convenient once-daily dosing
- Long half-life supports sustained antibacterial action
- Effective against common skin and soft tissue pathogens
- Helps manage wounds and abscesses
- Supports the treatment of respiratory tract infections
- Useful during surgical interventions
- Excellent pharmacokinetic profile
- Promotes better treatment compliance
- Trusted veterinary antibiotic therapy
- Suitable for dogs
COMPOSITION
Available Strengths
| Product |
Strength |
| Pawxy 100 |
100 mg Tablet |
| Pawxy 200 |
200 mg Tablet |
Pharmacological Class
Oral Broad-Spectrum Cephalosporin Antibiotic
How Pawxy Works
Pawxy belongs to the cephalosporin group of antibiotics and works by interfering with bacterial cell wall synthesis, resulting in bacterial cell death. Its time-dependent antibacterial activity ensures sustained effectiveness against susceptible organisms throughout the dosing interval.
INDICATIONS / USES
Pawxy is recommended for the treatment and management of:
- Skin Infections
- Wound Infections
- Abscesses
- Respiratory Tract Infections
- Soft Tissue Infections
- Surgical Intervention Support
- Bacterial Infections Caused by Susceptible Organisms
Effective Against Susceptible Strains of:
- Staphylococcus intermedius
- Staphylococcus aureus
-
Streptococcus canis (Group G, Beta-Hemolytic)
- Escherichia coli
- Pasteurella multocida
- Proteus mirabilis
DOSAGE & ADMINISTRATION
Species
Dogs
Method of Administration
Oral Administration
Recommended Dosage
5–10 mg per kg body weight once daily
Or as directed by the veterinarian.
Dose Guide – 5 mg/kg Daily
| Weight of Dog |
100 mg Tablets |
200 mg Tablets |
| 10 kg |
½ Tablet |
— |
| 20 kg |
1 Tablet |
— |
| 30 kg |
1½ Tablets |
— |
| 40 kg |
— |
1 Tablet |
| 60 kg |
1 Tablet |
1 Tablet |
Dose Guide – 10 mg/kg Daily
| Weight of Dog |
100 mg Tablets |
200 mg Tablets |
| 5 kg |
½ Tablet |
— |
| 10 kg |
1 Tablet |
— |
| 20 kg |
— |
1 Tablet |
| 30 kg |
1 Tablet |
1 Tablet |
| 40 kg |
— |
2 Tablets |
| 60 kg |
— |
3 Tablets |
Always follow the veterinarian's dosage recommendations based on the infection type and severity.
AVAILABLE SIZES
| Presentation |
MRP |
| Pawxy 100 (1 x 10 Tablets) |
₹207 |
| Pawxy 200 (1 x 10 Tablets) |
₹280 |
PRODUCT INFORMATION
|
|
| Brand |
Neo Kumfurt |
| Product Name |
Pawxy |
| Product Type |
Broad-Spectrum Antibiotic Tablets |
| Suitable For |
Dogs |
| Use For |
Skin Infections, Wounds, Abscesses & Respiratory Infections |
| Form |
Tablets |
| Class |
Cephalosporin Antibiotic |
